Torrent Pharma Schedules May 22 Earnings Call

Torrent Pharmaceuticals Ltd. has scheduled an investor and analyst conference call for May 22, 2026, to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2026. The call begins at 6:30 PM IST and will include dial-in information for participants.

Investor Focus

This call is a key event for investors and analysts to assess Torrent Pharma's financial health, operational performance, and market standing. Management is expected to outline their strategy and offer guidance for the coming periods.

Company Profile

Torrent Pharmaceuticals is a significant Indian pharmaceutical company with a broad portfolio including finished formulations, APIs, and branded generics. It operates in India and internationally, with a presence in markets like the USA, Brazil, and Germany.

Market Context

The company competes with major pharmaceutical firms such as Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., and Cipla Ltd. Investors will likely compare Torrent Pharma's performance against peers in key segments like generics and emerging markets.

Recent Financials

• Consolidated revenue grew from ₹10,398 crore in FY24 to ₹11,196 crore in FY25.
• Consolidated Profit After Tax (PAT) increased from ₹1,472 crore in FY24 to ₹1,652 crore in FY25.

What to Track

Investors should focus on the official results release before the call. Key elements to monitor during the call include management commentary on growth drivers, margin performance, and forward-looking guidance, as well as analyst Q&A.